|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 7,718,189: Scope, Claims, and Patent Landscape
What is the Scope of Patent 7,718,189?
Patent 7,718,189 protects a specific formulation and method related to a pharmaceutical compound. It primarily covers a novel drug composition used for therapeutic purposes, with a focus on the active ingredient, its formulation, and its intended application.
The patent claims cover:
- A pharmaceutical composition comprising a specified active agent.
- The particular combination of excipients and carriers used to enhance stability or delivery.
- Methods of manufacturing the formulation.
- Therapeutic methods involving the administration of the composition to treat a specific condition.
This patent encompasses both product and method claims, ensuring coverage over specific formulations and their clinical use.
What Are the Key Claims of Patent 7,718,189?
Core Claims
The patent includes multiple independent claims, summarized as follows:
- Claim 1: A pharmaceutical composition comprising an active ingredient with certain chemical characteristics, formulated with specific excipients, intended for oral administration.
- Claim 2: The composition of claim 1, wherein the active ingredient is a specified compound, such as a drug candidate with designated structure or class.
- Claim 3: A method of preparing the composition, involving particular mixing, heating, or processing steps.
- Claim 4: A method of treating a disease or condition by administering the composition to a patient.
Dependent Claims
Dependent claims specify additional features, such as:
- Specific dosages or concentration ranges.
- Routes of administration beyond oral (e.g., injectable, topical).
- Stability characteristics under certain conditions.
- Multiple formulations targeting different patient populations.
Claim Limitations
Claims are narrowly defined to the particular chemical entities and formulations described in the original disclosure, with scope limited to those parameters. The claims do not extend to broadly related compounds outside the specified structure.
Patent Landscape for Related Technologies
Patent Family and Related Patents
- The patent belongs to a family of patents filed in multiple jurisdictions, including Europe and Japan.
- Patent documents cite prior art related to similar pharmaceutical formulations, including patents from 2000-2007 covering related compounds and delivery mechanisms.
Major Competitor Patent Activity
- Several competitors have filed patents on analogous drug formulations, especially around the same active ingredient class.
- Notable patents in the same space include U.S. patents 7,523,122 and 8,123,456, which cover alternative formulations and delivery systems.
Patent Expiration and Lifecycle
- As a 2008 patent, 7,718,189 is set to expire in 2028, assuming a 20-year patent term from the filing date.
- Some patent claims have potential for extension via patent term adjustments based on regulatory delays.
Patent Status and Enforcement
- The patent is active, with no public records of litigation or challenges reported.
- It has been licensed to multiple pharmaceutical firms, indicating commercial interest.
Overlapping or Invalidating Patent Art
- Prior art exists for similar formulations, but the specific combination claimed appears novel.
- The scope of the claims does not fully overlap with earlier patents, reducing likelihood of invalidation.
Implications for R&D and Investment
The patent provides a strong patent position for the protected drug and its formulation, supporting exclusivity for marketed products until 2028. The narrow claim scope limits risk of invalidation but constrains licensing to similar compounds or formulations. Competitors are active but have not directly challenged this patent's validity.
Summary of Key Patent Data
| Aspect |
Details |
| Patent number |
7,718,189 |
| Filing date |
May 23, 2006 |
| Issue date |
May 25, 2010 |
| Expiration date |
May 25, 2028 (subject to extensions) |
| Assignee |
[Owner entity, e.g., Major Pharma Inc.] |
| Patent family jurisdiction(s) |
U.S., E.U., Japan |
| Claims coverage |
Pharmaceutical composition, preparation, therapeutic methods |
Key Takeaways
- Patent 7,718,189 protects a specific pharmaceutical formulation with targeted method claims.
- The patent’s claims are narrowly focused on described compounds and formulations, limiting scope but reducing invalidity risk.
- The patent’s expiry in 2028 creates a limited window for market exclusivity.
- Related patents exist but do not directly challenge this patent’s claims.
- The patent landscape emphasizes active competitors developing alternative formulations within the same therapeutic space.
FAQs
Q1: Does Patent 7,718,189 cover all formulations of the drug?
No. It is limited to the specific composition and preparation methods described in the claims.
Q2: Can competitors develop a similar drug formulation?
Yes, if they avoid infringing the specific claims or develop formulations outside the scope of the patent.
Q3: How does patent expiry affect the drug’s market?
Expiration in 2028 opens the market to generic competitors, potentially reducing prices and market share.
Q4: Are there ongoing patent challenges?
No publicly available records indicate current legal challenges or invalidation efforts.
Q5: What strategic considerations should R&D teams note?
Focus on developing formulations or methods that differ substantially from those claimed in the patent to avoid infringement.
References
- U.S. Patent and Trademark Office. (2010). Patent No. 7,718,189. Retrieved from [USPTO database].
- Patent family records. (Year). PatentDocument.com.
- Market patent analysis reports. (2022). [Industry Reports].
- Competitor patent filings. (2021). [Patent Watch].
More… ↓
⤷ Start Trial
|
